Amylyx Pharmaceuticals Inc AMLX Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	391.45M	407.96M	453.59M	466.58M	517.45M	417.46M	332.16M	250.71M
Total Current Assets	382.13M	389.05M	427.39M	434.11M	464.67M	410.53M	326.72M	245.26M
Cash and Equivalents	62.53M	114.56M	247.76M	135.26M	170.2M	170.55M	75M	71.84M
Total Non-Current Assets	11.93M	18.91M	26.19M	32.47M	55.47M	9.38M	6.91M	5.45M
Total Liabilities	50.85M	55.31M	67.22M	48.18M	84.02M	93.02M	70.85M	54.51M
Total Current Liabilities	46.61M	51.62M	64.08M	45.62M	82.04M	91.64M	70.08M	53.92M
Total Non-Current Liabilities	4.24M	3.69M	3.14M	2.57M	1.98M	1.38M	772k	595k
Common Equity	7k	7k	7k	7k	7k	7k	7k	7k
Retained Earnings	-354.22M	-352.65M	-330.57M	-309.68M	-304.95M	-423.74M	-496.44M	-569.15M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	3.22M	14.1M	105.61M	391.45M	517.45M
Total Current Assets	3.2M	13.64M	104.95M	382.13M	464.67M
Cash and Equivalents	3.07M	12.88M	50.19M	62.53M	170.2M
Total Non-Current Assets	-25.36M	-66.73M	-151.17M	340.61M	433.43M
Total Liabilities	20.9M	8.77M	17.43M	50.85M	84.02M
Total Current Liabilities	4.53M	7.33M	17.4M	46.61M	82.04M
Total Non-Current Liabilities	31.3M	1.7M	35k	4.24M	1.98M
Total Equity	-25.36M	-66.73M	-151.17M	340.61M	433.43M
Common Equity	1,000	1,000	1,000	7k	7k
Retained Earnings	-25.63M	-67.91M	-155.85M	-354.22M	-304.95M